Here are 10 of CFRA analysts' top growth stocks to buy that have reported at least 15% annual revenue growth in the past ...
Cadrenal Therapeutics, Inc. ( ($CVKD) ) has provided an announcement. On December 23, 2025, Cadrenal Therapeutics, Inc. filed a prospectus ...
StandardAero, Inc. (NYSE:SARO) is one of the best aerospace and defense stocks to buy according to Wall Street analysts. On ...
TipRanks on MSN
NextCure launches at-the-market stock offering program
NextCure ( ($NXTC) ) has shared an announcement. On December 19, 2025, NextCure, Inc. entered into an at-the-market offering agreement with H.C.
Valuation increases surge in October, taking market valuation to a slight discount. Big gets bigger, and concentration becomes more concentrated. Style and sector dynamics: growth premium shrinks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback